Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dry eye showdown: new drop takes on market leader

NCT ID NCT07593885

First seen May 20, 2026 · Last updated May 20, 2026 · Updated 1 time

Summary

This study tests whether a new eye drop, Artelac Complete MDO, works as well as the existing VISMED MULTI for people with moderate to severe dry eye. About 160 adults will use one of the two drops for 90 days. The goal is to see if Artelac is a safe and effective alternative for easing dry eye symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Augen & Haut Zentrum-Praxis Dr. Jacobi

    RECRUITING

    Nuremberg, Bavaria, 90403, Germany

  • Augen-Zentrum-Nordwest

    NOT_YET_RECRUITING

    Ahaus, North Rhine-Westphalia, 48683, Germany

  • Chiemsee Augentagesklinik, Prien

    NOT_YET_RECRUITING

    Bad Endorf, Bavaria, 83093, Germany

  • University Saarland Medical Center

    NOT_YET_RECRUITING

    Homburg, Saarland, 66421, Germany

  • Universitäts-Augenklinik Heidelberg

    NOT_YET_RECRUITING

    Heidelberg, Baden-Wurttemberg, 69120, Germany

Conditions

Explore the condition pages connected to this study.